Evidence map›Paper›PMID 33681831›Full record

ReviewMed (New York, N.Y.)2021

A clinician's primer on epidemiology for COVID-19.

Azman Rashid, Karla Therese L Sy, Jacob M Cabrejas, Brooke E Nichols, Nahid Bhadelia, Eleanor J Murray

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Med (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Azman RashidBoston University School of Public Health, Boston, MA, USA.
Karla Therese L SyDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Jacob M CabrejasBoston University School of Medicine, Boston, MA, USA.
Brooke E NicholsDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Nahid BhadeliaSection of Infectious Diseases, Boston University School of Medicine, Boston, MA, USA.
Eleanor J MurrayBoston University School of Public Health, Boston, MA, USA.

Funding

HPV vaccination efficacy for cervical cancer prevention in young women with perinatal HIV infectionR21HD098733 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MURRAY, ELEANOR · 2019 to 2020
$467k
NICHD NIH HHS R21 HD098733
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has resulted in a concomitant deluge of medical, biological, and epidemiologic research. Clinicians are interested in incorporating the best new evidence-based practices when treating individuals with COVID-19 and instituting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission prevention protocols. However, without sufficient background knowledge, evaluating epidemiologic studies can be challenging, and failure to identify sources of bias could lead to poor treatment decisions. Here we provide a brief primer on key concepts and terms related to COVID-19 epidemiology to provide clinicians with a starting point for evaluating the emerging COVID-19 literature.

Indexed as

COVID-19HumansPandemicsSARS-CoV-2

Identifiers

PMID33681831
PMCPMC7914024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.